You just read:

CureFAKtor Pharmaceuticals Demonstrates Novel Focal Adhesion Kinase (FAK) Inhibitor Y15 Decreased Glioblastoma Tumor Growth & Increased Lung & Colon Cancer Cell Death

News provided by

CureFAKtor Pharmaceuticals, LLC

Nov 14, 2011, 08:30 EST